{
    "code": 0,
    "data": [
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q3 & M9 FY26",
            "news_id": "f74804f7-c710-4c6b-9e21-d4d9b31ccfe4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4a06638-c881-49e1-88ce-e7de62e608d4.pdf",
            "news_date": "2026-02-12 18:01:01",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q3 & M9 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4a06638-c881-49e1-88ce-e7de62e608d4.pdf",
            "news_date": "2026-02-12 18:01:01"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation On Communication To Members Regarding Tax Deducted At Source For Interim Dividend",
            "news_body": "Intimation on communication to members regarding Tax Deducted at Source for Interim Dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=476bfe7e-7d4e-40a3-88a3-c9be8a9895d2.pdf",
            "news_date": "2026-02-12 16:34:41"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53cbd620-26b0-4840-88c7-70c0da9e89f8.pdf",
            "news_date": "2026-02-12 14:40:26"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of newspaper publication of Un-Audited Financial Results for the Q3&9M FY2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2277841c-efc8-4de9-8bb7-5f013a60a86b.pdf",
            "news_date": "2026-02-12 14:31:05"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q3 & M9 FY26",
            "news_id": "c3f2a354-26f9-47ec-9d83-5180d7527cfe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=763318ae-b6f3-4301-81b5-28ce5ceebbae.pdf",
            "news_date": "2026-02-12 12:53:37",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q3 & M9 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=763318ae-b6f3-4301-81b5-28ce5ceebbae.pdf",
            "news_date": "2026-02-12 12:53:37"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release- Financial Results for the quarter and nine months ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d728dbc-deb7-4e89-b35d-c682c17567e7.pdf",
            "news_date": "2026-02-11 18:17:35"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Board approved Interim Dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48908e6f-5ff9-4ff1-9c11-ad8141d564b5.pdf",
            "news_date": "2026-02-11 14:52:17"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2025",
            "news_body": "Outcome of the Board Meeting and submission of Un-Audited Financial Results for the quarter and nine months ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=908eefad-3df6-4df9-98e5-3d74aaf79399.pdf",
            "news_date": "2026-02-11 14:47:36"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2025",
            "news_body": "Un-Audited Financial Results for the quarter and nine months ended 31st December 2025",
            "news_id": "0cb16dd4-7435-40ac-b7fb-4ff3e6007ebb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ca83733-485b-44f5-a103-7b49060f19ae.pdf",
            "news_date": "2026-02-11 14:44:12",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2025",
            "news_body": "Un-Audited Financial Results for the quarter and nine months ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ca83733-485b-44f5-a103-7b49060f19ae.pdf",
            "news_date": "2026-02-11 14:44:12"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of analyst / investor conference call - Q3 & M9 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64dd61fd-03fb-40bc-b0ce-9236210a9f07.pdf",
            "news_date": "2026-02-04 16:49:34"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Disclosure pursuant to regulation 30 of SEBI(listing Obligations and Disclosure Requirements) Regulations2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b9957b5-e479-4ce1-8b1a-0f404914627f.pdf",
            "news_date": "2026-01-27 18:28:48"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Notice Of The Board Meeting",
            "news_body": "IOL Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve the Un-audited Financial Results of the Company for the quarter and nine months ended 31st  December 2025 and to consider declaration of Interim Dividend for FY 2025-26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cbec6aa-66a9-459f-816b-9f38dc866eb6.pdf",
            "news_date": "2026-01-23 14:09:34"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f428d021-39ed-4c79-8f67-f8566ec64264.pdf",
            "news_date": "2026-01-08 17:22:37"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8347f8f2-b8c2-499c-ad31-e7bbd04ac73f.pdf",
            "news_date": "2025-12-29 15:07:03"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "EDQM Issued CEP Certificate For MINOXIDIL",
            "news_body": "CEP Certificate for MINOXIDIL",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31b3f849-be28-4b53-9575-083ee3e93acd.pdf",
            "news_date": "2025-12-05 15:33:04"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0658fc2b-2f83-4b66-aef3-dfe55a5795d5.pdf",
            "news_date": "2025-11-26 17:20:25"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning call transcript",
            "news_id": "d1da2805-50e1-437f-a1a0-e3deffb59171",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94dc8ddb-b216-4d23-a04c-7778ad2f7951.pdf",
            "news_date": "2025-11-19 17:56:32",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning call transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94dc8ddb-b216-4d23-a04c-7778ad2f7951.pdf",
            "news_date": "2025-11-19 17:56:32"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q2 & H1 FY26",
            "news_id": "8e216b9e-aa75-4cee-9e11-f4e4aa5fd249",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81eb8c14-c7f3-4fb7-9935-485436404cb7.pdf",
            "news_date": "2025-11-13 16:16:06",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q2 & H1 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81eb8c14-c7f3-4fb7-9935-485436404cb7.pdf",
            "news_date": "2025-11-13 16:16:06"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "70ecacdb-7944-4100-be5a-f584dc08b5a3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94b73f8b-4b36-46c7-bfcd-bf049d2e084a.pdf",
            "news_date": "2025-11-12 17:10:35",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94b73f8b-4b36-46c7-bfcd-bf049d2e084a.pdf",
            "news_date": "2025-11-12 17:10:35"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of Newspaper publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=442e530b-749e-400b-99ce-60a4281c4e84.pdf",
            "news_date": "2025-11-12 16:11:47"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release - Financial Results for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=365869e6-ad1a-4748-a3d7-ba8760a9fd87.pdf",
            "news_date": "2025-11-11 18:08:13"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Un-Audited Financial Results for the quarter and half year ended 30th September 2025",
            "news_id": "d00f09a9-5eb0-4f08-85ee-8574dd3db309",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddfc9683-6dd5-46bd-a1d7-b156b4175656.pdf",
            "news_date": "2025-11-11 15:37:36",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Un-Audited Financial Results for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddfc9683-6dd5-46bd-a1d7-b156b4175656.pdf",
            "news_date": "2025-11-11 15:37:36"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Outcome of the Board Meeting and submission of Un-Audited Financial Results for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6d34969-68b6-4316-bc93-f8c1689d7795.pdf",
            "news_date": "2025-11-11 15:31:12"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of analyst / investor conference call - Q2 & H1 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4b96097-a2cc-4657-b486-bbf3007ce80b.pdf",
            "news_date": "2025-11-10 16:59:15"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Notice Of Board Meeting",
            "news_body": "IOL Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve Un-audited Financial Results of the Company for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=290aa06e-1d08-48e0-a019-374927f02fd6.pdf",
            "news_date": "2025-11-04 16:54:32"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "EDQM Issued CEP Certificate For Sitagliptin Phosphate Monohydrate",
            "news_body": "CEP Certificate for Sitagliptin Phosphate Monohydrate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe50ea2f-b3ea-4e68-9ea9-15036d924cf7.pdf",
            "news_date": "2025-10-27 17:40:43"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Incorporation Of Wholly Owned Subsidiary",
            "news_body": "Intimation of incorporation of wholly owned subsidiary",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2fdc9f50-ac70-470e-8890-1d33e7298d55.pdf",
            "news_date": "2025-10-24 17:43:48"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Vasudeva Commercials Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5B8895A0_1066_4D09_94BC_13125F403D8F_153421.pdf",
            "news_date": "2025-10-18 15:34:27"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "EDQM Issued CEP Certificate For Pantoprazole Sodium Sesquihydrate Process-III",
            "news_body": "EDQM issued CEP Certificate for Pantoprazole Sodium Sesquihydrate Process-III",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ce87ed4-8823-4457-b5e5-501213115aa0.pdf",
            "news_date": "2025-10-15 15:30:37"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate received from RTA under Reg. 74(5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa3edf60-51a6-4aa9-a862-26eb18d6e7b9.pdf",
            "news_date": "2025-10-07 17:15:50"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation On Receipt Of Request For Re-Lodgement Of Transfer Requests Of Physical Shares",
            "news_body": "Intimation on receipt of request for re-lodgement of transfer requests of physical shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97bf3ef4-e6fa-406f-9d88-6f0e924b0d65.pdf",
            "news_date": "2025-10-01 17:49:11"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50dd02c5-6108-4ed8-8933-f8948976f357.pdf",
            "news_date": "2025-09-26 16:02:48"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Notice published in Newspaper",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=397d5bb7-736f-4754-be44-087d44a1c3ac.pdf",
            "news_date": "2025-09-25 16:43:31"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Dispatch Of Reminder Letter To Shareholders To Update KYC",
            "news_body": "Dispatch of reminder letter to shareholders to update KYC",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7bb6903-c283-4e98-bc33-a31ce409ce8d.pdf",
            "news_date": "2025-09-24 17:03:31"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst/Institutional Investor Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e8202f3-68e1-474c-a058-6ae1eb8f96d0.pdf",
            "news_date": "2025-09-09 17:25:07"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Clarification On Volume Movement",
            "news_body": "Clarification on Volume Movement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d660b7a-963b-405e-8801-83ba7455a334.pdf",
            "news_date": "2025-09-09 13:20:12"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from IOL Chemicals & Pharmaceuticals Ltd",
            "news_body": "The Exchange has sought clarification from IOL Chemicals & Pharmaceuticals Ltd on September 9 2025 with reference to Movement in Volume.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-09-09 12:10:11"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement 100-Day Campaign titled Saksham Niveshak",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=557756fd-aecc-4b64-8ede-a60791693b5f.pdf",
            "news_date": "2025-08-29 17:23:52"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Voting Results along with Scrutinizers Report with regard to the 38th Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b21890c-15cb-4e0a-8f61-d0e8b7bd3852.pdf",
            "news_date": "2025-08-22 17:10:54"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Proceedings of 38th Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2856d654-eecd-4d2f-a1cd-e4dedae42772.pdf",
            "news_date": "2025-08-22 16:55:57"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earning call",
            "news_id": "69ab68af-14d0-4572-9f88-f72a13eb9a84",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be32446f-df9d-4cd7-9e01-f5c8ae5457e7.pdf",
            "news_date": "2025-08-13 12:37:19",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earning call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be32446f-df9d-4cd7-9e01-f5c8ae5457e7.pdf",
            "news_date": "2025-08-13 12:37:19"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst/Institutional Investor Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1533d859-9e7b-4ead-9804-d9a40463847b.pdf",
            "news_date": "2025-08-12 14:11:36"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst/Institutional Investor Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0166bccf-23c2-4e89-b1bc-78f6ac1fc19a.pdf",
            "news_date": "2025-08-12 14:09:50"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q1 FY2026",
            "news_id": "ffdee26a-1316-40a9-96a9-c2a4098fe06f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cd0111d-6d17-47e8-9f79-7335f9ef2d09.pdf",
            "news_date": "2025-08-08 18:33:21",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q1 FY2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cd0111d-6d17-47e8-9f79-7335f9ef2d09.pdf",
            "news_date": "2025-08-08 18:33:21"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c63e51bd-3168-4273-b3a3-4aa7aeef5643.pdf",
            "news_date": "2025-08-08 15:25:18"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q1 FY2026",
            "news_id": "0b42541d-02be-44f5-92fe-8edd22ccaf13",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da87a96a-d114-4778-8717-fcddd91e873a.pdf",
            "news_date": "2025-08-07 18:42:35",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q1 FY2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da87a96a-d114-4778-8717-fcddd91e873a.pdf",
            "news_date": "2025-08-07 18:42:35"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release - Financial Results for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a00450d-951d-487c-a1e3-40b087737618.pdf",
            "news_date": "2025-08-07 18:36:24"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter Ended 30Th June 2025",
            "news_body": "Outcome of the Board Meeting and submission of Un-Audited Financial Results for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b496e60b-8560-4625-9e57-927cb0ea4027.pdf",
            "news_date": "2025-08-07 14:32:06"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended 30Th June 2025",
            "news_body": "Un-Audited Financial Results for the quarter ended 30th June 2025",
            "news_id": "9ada4ff1-5ca5-4718-b52a-5de7c4751383",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7a91e1d-ada8-4879-8de9-d48084006cdb.pdf",
            "news_date": "2025-08-07 14:30:09",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended 30Th June 2025",
            "news_body": "Un-Audited Financial Results for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7a91e1d-ada8-4879-8de9-d48084006cdb.pdf",
            "news_date": "2025-08-07 14:30:09"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Pursuant To Regulation 36(1)(B) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation pursuant to Regulation 36 (1) (b) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e9db217-113f-4d3c-9655-90f8ff7b25b7.pdf",
            "news_date": "2025-08-05 11:21:32"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of analyst / investor conference call - Q1 & FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bdd170fa-11bf-4d68-b6af-b7d7086e6e40.pdf",
            "news_date": "2025-08-04 17:54:26"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of Notice published in Newspapers",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7bdc7f87-4077-48c6-bf44-62beac260ffa.pdf",
            "news_date": "2025-08-04 17:48:16"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copy of the Notice published in Newspapers",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=591406a2-8d45-413c-b9e0-0372d4c33bf4.pdf",
            "news_date": "2025-08-01 16:32:37"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility and Sustainability Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8c1d884-e802-4f50-9782-8b7fa1f5ecc4.pdf",
            "news_date": "2025-07-31 15:09:03"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Integrated Annual Report 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc0de24d-5d21-46ac-91f5-840c4877eba2.pdf",
            "news_date": "2025-07-31 14:39:07"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Notice Of 38Th Annual General Meeting (AGM) Of The Company",
            "news_body": "Notice of the 38th Annual General Meeting of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45ce1076-43d6-4460-90c6-83065c42fdd1.pdf",
            "news_date": "2025-07-31 14:20:34"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Notice Of The Board Meeting",
            "news_body": "IOL Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 inter alia to consider and approve the Un-Audited Financial Results of the Company for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1937859f-947a-473c-96b6-0ed657220e55.pdf",
            "news_date": "2025-07-28 16:58:08"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst/Institutional Investor Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f98949fa-b201-4e5c-9c27-c0992bacc75a.pdf",
            "news_date": "2025-07-22 17:43:25"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=378ebe43-3e45-41a4-a259-e501f0173cff.pdf",
            "news_date": "2025-07-22 17:37:51"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8319bfed-c39d-4325-b4b4-8d6ebffc8133.pdf",
            "news_date": "2025-07-15 17:10:45"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Reaffirmation of Credit Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfc4a6e6-4481-4656-93cb-31cfff0284f6.pdf",
            "news_date": "2025-07-01 17:35:59"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=00dbfa92-2845-4d28-ab27-64b0326d311a.pdf",
            "news_date": "2025-06-26 16:05:59"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "REACH Registration For Acetic Anhydride",
            "news_body": "REACH Registration for Acetic Anhydride",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ebca047-74d6-4d60-90ba-76a1ce7f7731.pdf",
            "news_date": "2025-06-13 17:56:56"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "IOL Awarded Ecovadis Silver Medal - Ranks Among The Top 15% Companies Globally",
            "news_body": "IOL Awarded Ecovadis Silver Medal-Ranks Among the Top 15% companies globally",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbac53e2-c6b9-47b7-bc10-19f1086843c4.pdf",
            "news_date": "2025-06-11 17:30:17"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earning Call",
            "news_id": "874090ae-bc7a-4c7d-bf0d-2ebe45a62738",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=882c5ebc-c90d-4d32-8c26-c8fb487750d1.pdf",
            "news_date": "2025-05-27 14:47:18",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earning Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=882c5ebc-c90d-4d32-8c26-c8fb487750d1.pdf",
            "news_date": "2025-05-27 14:47:18"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q4 & FY2025",
            "news_id": "e31f0bc8-8ff3-4993-980e-5f65d376d717",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd23a6b9-f149-4961-8a5a-f0cdfcbb646c.pdf",
            "news_date": "2025-05-20 17:39:49",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q4 & FY2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd23a6b9-f149-4961-8a5a-f0cdfcbb646c.pdf",
            "news_date": "2025-05-20 17:39:49"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q4 & FY25",
            "news_id": "9ed5f4b6-7a53-41e7-8ca8-b190640ca941",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=278b0efc-94ac-408c-808e-fb328bc7b857.pdf",
            "news_date": "2025-05-19 18:35:20",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q4 & FY25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=278b0efc-94ac-408c-808e-fb328bc7b857.pdf",
            "news_date": "2025-05-19 18:35:20"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "submission of newspaper publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73907540-a1d5-4a3d-9e06-9da20c5b58b2.pdf",
            "news_date": "2025-05-17 14:00:59"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Change in Management: Re-appointment of Mr Vikas Gupta as Joint Managing Director and Appointment of Secretarial Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07fb92ce-cf1b-4d8f-84c6-12dbf991f67c.pdf",
            "news_date": "2025-05-17 12:06:18"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release - Financial Results for the quarter and year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71dc433d-bd4a-48d0-b19d-99faccb0b341.pdf",
            "news_date": "2025-05-16 21:23:10"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 16Th May 2025",
            "news_body": "Outcome of the Board Meeting dated 16th May 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36b680a0-9fd0-4270-8bf5-26e18236ad2a.pdf",
            "news_date": "2025-05-16 19:10:47"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March 2025",
            "news_body": "Audited Financial Results for the quarter and year ended 31st March 2025",
            "news_id": "d5ae9cb8-2e3e-4435-a37b-584df09e5505",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3b62009-dba0-4ff6-80c8-16ee4994867e.pdf",
            "news_date": "2025-05-16 19:06:37",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March 2025",
            "news_body": "Audited Financial Results for the quarter and year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3b62009-dba0-4ff6-80c8-16ee4994867e.pdf",
            "news_date": "2025-05-16 19:06:37"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual secretarial Compliance report for the year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=999d749d-7c9b-4b96-942c-9427170dd003.pdf",
            "news_date": "2025-05-15 19:38:57"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of analyst / investor conference call - Q4 & FY25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e120f8ad-c03d-4cc6-bd8b-285fc1daafef.pdf",
            "news_date": "2025-05-14 18:37:03"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Notice Of The Board Meeting",
            "news_body": "IOL Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2025 inter alia to consider and approve Audited Financial Results of the Company for the quarter and year ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7be7ec26-599f-48ad-b34a-6cd33e808723.pdf",
            "news_date": "2025-05-06 17:15:05"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under SEBI (LODR) Regulations 2015 - CDE China Approved Ibuprofen",
            "news_body": "Intimation under SEBI (LODR) Regulations 2015 - CDE China approved \"Ibuprofen\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6db07fa2-682d-4085-b130-ede1ce8b925b.pdf",
            "news_date": "2025-04-28 17:38:56"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015 - minor gas leakage incident at plant",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb32a986-f4b0-4c02-9393-0580753c02bf.pdf",
            "news_date": "2025-04-28 14:27:05"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Compliance certificate under Reg 74 (5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12ab8f69-91eb-455a-91fa-6c58bb40f820.pdf",
            "news_date": "2025-04-04 17:17:47"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst / Investor Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fa194ec-94d5-4347-89e1-1c8162968be0.pdf",
            "news_date": "2025-04-03 17:37:57"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a64beec3-3d2a-4e36-9d7f-32ed1836d03b.pdf",
            "news_date": "2025-03-26 09:40:44"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "1. Commencement of New Unit 11 for Paracetamol production\r\n2. Expansion of Clopidogrel manufacturing facility (Unit-5)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5262c26-5a6b-4347-84e1-ad48323eab1d.pdf",
            "news_date": "2025-03-24 20:08:32"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of analyst /institutional investor meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae225bb0-3853-46eb-b970-c559967d7c45.pdf",
            "news_date": "2025-03-20 18:51:49"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Disclosure pursuant to Regulation 30",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b59e7bea-b3f3-4380-bd55-39763fd3098f.pdf",
            "news_date": "2025-03-20 18:31:50"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Intimation",
            "descriptor": "Sub-division / Stock Split",
            "caption": "Corporate Action-Updates on intimation of Sub division / Stock Split",
            "news_body": "Confirmation of Credit of Shares by Depositories with regard to sub-division /split of Equity Shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32394616-b7ae-40a3-988b-c507f9b3c049.pdf",
            "news_date": "2025-03-13 21:12:48"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "EDQM Issued CEP Certificate For QUETIAPINE FUMARATE",
            "news_body": "EDQM issued CEP Certificate for \"QUETIAPINE FUMARATE\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0b1c29a-b84d-4f01-bc18-dc210ccbfd2b.pdf",
            "news_date": "2025-03-05 17:05:36"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Intimation",
            "descriptor": "Sub-division / Stock Split",
            "caption": "Corporate Action-Updates on intimation of Sub division / Stock Split",
            "news_body": "Intimation of New ISIN with respect to Sub-division/split of face value of Equity Shares of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f39a916-3139-4ebb-851d-c0009313eedc.pdf",
            "news_date": "2025-03-05 17:02:16"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings conference call",
            "news_id": "cba8963a-d4be-40d7-b179-3a61ab8573ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41a08411-de16-44b4-9bbd-4312ed31c978.pdf",
            "news_date": "2025-02-18 14:41:06",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings conference call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41a08411-de16-44b4-9bbd-4312ed31c978.pdf",
            "news_date": "2025-02-18 14:41:06"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation on publication of Newspaper advertisement",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b80b74fd-2fa5-4e77-a106-c1127afbd736.pdf",
            "news_date": "2025-02-15 13:25:00"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q3-FY2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ea876e8-47d0-4a09-ae2f-0ad1af13d61b.pdf",
            "news_date": "2025-02-14 18:00:24"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation On Communication To Members Regarding Tax Deduction At Source",
            "news_body": "Intimation on communication to members regarding Tax Deducted at Source for Interim Dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0767f93d-0142-4813-a51b-c83902ce6f36.pdf",
            "news_date": "2025-02-14 14:40:42"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q3 FY2025",
            "news_id": "4ec66c87-eede-4411-9beb-873dee420bce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6ed3a16-daa9-4976-a8f3-33c3ee2b5a90.pdf",
            "news_date": "2025-02-13 18:19:31",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q3 FY2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6ed3a16-daa9-4976-a8f3-33c3ee2b5a90.pdf",
            "news_date": "2025-02-13 18:19:31"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of newspaper publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4a9b372-4145-4b81-95b9-759ae68f8edd.pdf",
            "news_date": "2025-02-13 17:13:20"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release: Financial Results for the quarter and nine months ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b901944-5607-43f6-9a7c-062004925dea.pdf",
            "news_date": "2025-02-12 20:17:27"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated Filling (Financial) for the quarter and nine months ended 31st December 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebc3ee05-9bf4-41a5-a52c-8f740c390448.pdf",
            "news_date": "2025-02-12 19:07:50"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Interim dividend Rs 4/- per equity share of face value of Rs 10 each",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d493f9a4-051d-4cff-8718-266686383175.pdf",
            "news_date": "2025-02-12 18:14:39"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Outcome of the Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b5909e1-0e19-4406-9eb6-502c64053b91.pdf",
            "news_date": "2025-02-12 18:08:46"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2024",
            "news_body": "Un-Audited Financial Results",
            "news_id": "befcb8e5-50b1-4acc-b56c-3f607e389b15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb8b40de-da84-473d-b519-ce94cba3a9ad.pdf",
            "news_date": "2025-02-12 18:05:15",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2024",
            "news_body": "Un-Audited Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb8b40de-da84-473d-b519-ce94cba3a9ad.pdf",
            "news_date": "2025-02-12 18:05:15"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Intimation",
            "descriptor": "Sub-division / Stock Split",
            "caption": "Corporate Action-Intimation of Sub division / Stock Split",
            "news_body": "Intimation of Record date 11th March 2025 for Sub division /Stock Split",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89295fbb-042d-490c-b9ce-8cd7e111e024.pdf",
            "news_date": "2025-02-07 18:27:33"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of analyst / investor conference call - Q3 & 9M-FY2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0848252c-3e74-4a49-bd29-0f31b4d10282.pdf",
            "news_date": "2025-02-07 16:29:53"
        },
        {
            "co_code": 1973,
            "bse_code": 524164,
            "isin": "INE485C01029",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Notice Of The Board Meeting",
            "news_body": "IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve the Un-Audited Financial Results of the Company for the Quarter and nine months ended 31st December 2024 and declare payment of Interim Dividend for FY 2024-25 if any.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3c42770-a9fb-4990-a808-c7c047cb6829.pdf",
            "news_date": "2025-02-04 17:45:19"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript",
            "news_id": "a31c0a57-20f3-4ebf-aeb0-65e26f9cf4e9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e89694a5-3b06-45b8-b3dd-9b51bd52884d.pdf",
            "news_date": "2024-11-26 18:13:49",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q2&H1-FY2025",
            "news_id": "468c0695-80e4-436e-851f-7773dcbae22c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1461270-00da-47d9-81c3-82e589d39551.pdf",
            "news_date": "2024-11-19 18:18:38",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q2 FY2025",
            "news_id": "04dda214-8e3e-4eb6-8175-ef2f30f44d96",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0577f9c7-a51f-4d5c-98fd-b88d31b82e7f.pdf",
            "news_date": "2024-11-18 16:31:53",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2024",
            "news_body": "Financial Results",
            "news_id": "0d576e1c-fba1-4879-86b7-9da86299f940",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12439bfd-cbdf-4361-80e0-c79658f42c1d.pdf",
            "news_date": "2024-11-14 17:00:28",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript",
            "news_id": "f6afe6cb-8989-40ec-877a-a46c7e0bc5a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98ca443d-a0fa-4939-98f9-3aede430d721.pdf",
            "news_date": "2024-08-20 15:48:59",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q1-FY2025",
            "news_id": "a73d4569-008c-4859-b8f3-0281a86c5693",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d320209f-85d3-41c6-b646-bfa92d72fe82.pdf",
            "news_date": "2024-08-13 14:48:46",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q1 FY2025",
            "news_id": "18f4f4eb-c6de-41e7-b0d8-3c4afd6caed0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d4e0ee6-7380-4d5f-a8ae-028a6c3e9d7c.pdf",
            "news_date": "2024-08-12 17:32:35",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended 30Th June 2024",
            "news_body": "Un-Audited Financial Results for the quarter ended 30th June 2024",
            "news_id": "d732caea-4f2a-4e6c-9333-dfbb4a9d7c7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7da5ca30-8d69-4623-877b-cd2c5935f7c1.pdf",
            "news_date": "2024-08-09 18:37:20",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call,post declaration of audited financial results fpr the quarter and year ended 31st March 2024",
            "news_id": "564c6457-8d5c-4828-a347-982d6d138f57",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d97f031c-fe8d-4906-baba-bfb7ebb45612.pdf",
            "news_date": "2024-05-21 17:08:30",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q4-2024 & FY2024",
            "news_id": "cf55eb89-3371-4ff8-8ee0-3835ca1cbad6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1ba900d-1182-4e72-89c2-ed990b947791.pdf",
            "news_date": "2024-05-16 17:58:51",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q4-2024 & FY2024",
            "news_id": "e2151405-bad6-4d17-9432-55aa58a0762c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=401a1c0a-205b-4650-8637-4f912e231bb2.pdf",
            "news_date": "2024-05-15 18:34:05",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Dated 14Th May 2024",
            "news_body": "Outcome of the Board meeting dated 14th May 2024",
            "news_id": "5ee002a6-a06b-42c8-9a8c-741682d9866a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=402e2a9a-babd-495d-9d6b-1720b9a9da8f.pdf",
            "news_date": "2024-05-14 16:59:22",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call, post declaration of audited financial results for the quarter and nine months ended   31st December 2023",
            "news_id": "ebe1d800-dcef-47c6-a45c-a44900d09195",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0f277eb-3924-4d04-b777-329db13181c7.pdf",
            "news_date": "2024-02-14 17:45:11",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results  Q3 & 9M FY24",
            "news_id": "b7a69368-80c2-4914-8224-cfcc713a8ebe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=168f61ea-257a-4561-8cb8-a952b0619458.pdf",
            "news_date": "2024-02-08 17:47:12",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q3 & M9 FY24",
            "news_id": "de75790b-f5b6-4574-9341-da8cc4a14d8d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17f56206-6b62-42e6-91c4-1774a3b34fac.pdf",
            "news_date": "2024-02-07 18:33:21",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Nine Months Ended 31St December 2023",
            "news_body": "Audited Financial Results for the quarter and nine months ended 31st December 2023",
            "news_id": "27536046-5933-4a53-a38d-75460b210785",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acb5dc07-2894-413f-b798-f8b2c4683644.pdf",
            "news_date": "2024-02-06 18:15:02",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earning Call 9th November 2023",
            "news_id": "897e9f20-e617-42e2-9b10-38bb6744ebad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19fb3bea-9b8c-4f80-9ac2-5f737bfff43b.pdf",
            "news_date": "2023-11-16 17:38:47",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results  Q2 & H1 FY24",
            "news_id": "e34ab0ea-d467-46c1-940d-de1a92171925",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=781752c0-1da5-41d6-83a2-d2e6f55035e2.pdf",
            "news_date": "2023-11-09 18:02:40",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q2 & H1 FY24",
            "news_id": "83f3b4a6-b082-472f-a0cc-350164cb37fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=114aff7c-8d41-43a1-96a9-63e8374ae196.pdf",
            "news_date": "2023-11-09 11:25:43",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter  And Half Year Ended 30Th September 2023",
            "news_body": "Please find attached herewith Audited Financial Results for the quarter and half year ended 30th September 2023",
            "news_id": "14a2ddd8-266d-4373-9e78-d8f79922a231",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d18fc22b-90a7-440f-b0c4-c73624cb7cbe.pdf",
            "news_date": "2023-11-08 16:06:17",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earning Conference on audited financial results for Q1FY24",
            "news_id": "9df5fef0-64f6-4957-995c-3ac083426d14",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f63768e-65a3-4f15-9db3-3382cb920e7c.pdf",
            "news_date": "2023-08-19 13:59:03",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results Q1FY24",
            "news_id": "f537c440-9799-497e-990f-2935a33b77a5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b499cbb-ae78-4c73-af96-f8bc07688e69.pdf",
            "news_date": "2023-08-16 18:52:41",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation - Q1FY24",
            "news_id": "249dd6d9-ae5d-44be-8e61-f17e3af3b5be",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f21f477f-8787-4e7b-8567-10970cd664a7.pdf",
            "news_date": "2023-08-14 19:28:18",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter  Ended 30Th June 2023",
            "news_body": "Audited Financial Results for the quarter ended 30th June 2023",
            "news_id": "0e296954-782f-4784-9884-8906fb5943ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa53b56d-17f0-4743-865b-e5662967637d.pdf",
            "news_date": "2023-08-09 18:05:13",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Conference Call, post declaration of audited financial results for the quarter and year ended 31st March 2023",
            "news_id": "35db3b72-f081-459b-add0-bccce235e0a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e68ea1f9-df93-4b28-9254-a2030811aeda.pdf",
            "news_date": "2023-05-17 17:34:43",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Call pertaining to the Financial Results 4Q & FY23",
            "news_id": "297a2827-c283-48ea-aa00-dff1f2c4fed4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc0b0c8b-01c5-4fdc-a99f-c4fb7933c3c6.pdf",
            "news_date": "2023-05-10 13:31:03",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "1b0c0a99-ed88-4d95-a7fb-12ca235e6b27",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=664d1893-4c50-469b-b2e4-8ec6c6434d01.pdf",
            "news_date": "2023-05-08 14:09:51",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting-Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended 31St March 2023",
            "news_body": "Audited Financial Results (Standalone & Consolidated) for the Quarter and Year ended 31st March 2023",
            "news_id": "9fbf3ccf-0a66-48a9-883d-572117464f80",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=419ac7bb-be60-4684-a935-8b0c9f79dff0.pdf",
            "news_date": "2023-04-28 13:54:51",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Analysts/Investors Conference Call pertaining to the Financial Results for Q3 & 9M FY23",
            "news_id": "2bcce80a-88da-4493-93b4-5219cd731843",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b77ac1fa-969a-402d-9d7c-c34c9d693447.pdf",
            "news_date": "2023-02-09 16:47:21",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "b96ac0ac-f87d-4c59-b5fb-0c395ed8b1a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bdff78af-4e20-43f4-906b-b0cfee6c8d25.pdf",
            "news_date": "2023-02-08 18:30:19",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 7Th February 2023 And Submission Of Audited Financial Results For The Quarter And Nine Months Ended 31St December 2022",
            "news_body": "Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our letter dated 1st February 2023, we wish to inform you that the Board of Directors in its meeting held on today i.e. 7th February 2023 has inter alia considered and approved:<BR> <BR> 1. The Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December 2022. Copy of the said Financial Results along with unmodified Auditors Report thereon is enclosed herewith as 'Annexure - 1'.<BR> <BR> 2. Declared an Interim Dividend of Rs. 4/- (Rupees four only) per Equity Share of Face Value Rs.10/- each for the Financial Year 2022-23.<BR> <BR> 3. Fixed 17th February 2023 (Friday) as the Record Date to determine the names of the equity shareholders, who shall be entitled to receive the above said Interim Dividend. The payment of the Interim Dividend shall be made to the eligible shareholders before 8th March 2023.<BR>",
            "news_id": "7aea45d3-dd3c-4e88-83c8-a2d16bf979fc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=420930fa-82e8-4e7a-b79f-b668c1097f84.pdf",
            "news_date": "2023-02-07 17:53:42",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Dated 7Th February 2023 And Submission Of Audited Financial Results For The Quarter And Nine Months Ended 31St December 2022",
            "news_body": "Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our letter dated 1st February 2023, we wish to inform you that the Board of Directors in its meeting held on today i.e. 7th February 2023 has inter alia considered and approved: <BR> <BR> 1. The Audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 31st December 2022. Copy of the said Financial Results along with unmodified Auditors Report thereon is enclosed herewith as 'Annexure - 1'.<BR> <BR> 2. Declared an Interim Dividend of Rs. 4/- (Rupees four only) per Equity Share of Face Value Rs.10/- each for the Financial Year 2022-23.<BR> <BR> 3. Fixed 17th February 2023 (Friday) as the Record Date to determine the names of the equity shareholders, who shall be entitled to receive the above said Interim Dividend. The payment of the Interim Dividend shall be made to the eligible shareholders before 8th March 2023.<BR> <BR> <BR>",
            "news_id": "b9ba49c0-5366-42e4-9d36-efbedf7b0271",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=986abaff-9cde-458a-8df6-1ae2761db5b7.pdf",
            "news_date": "2023-02-07 17:49:57",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions in the format specified under SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22nd November, 2021, for the half year ended on 30th September 2022.",
            "news_id": "82d506d8-ed7e-4809-adda-dd0317056185",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7704ee1c-d700-4a49-bf39-4df8e7403cab.pdf",
            "news_date": "2022-11-23 12:16:37",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Analysts/Investors Conference Call Pertaining To The Financial Results For Q2 & FY23",
            "news_body": "Audio Recording of Analysts/Investors Conference Call pertaining to the Financial Results for Q2 & FY23",
            "news_id": "e59e809e-bd90-4207-a20f-a08db1d2114b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4ceb51b-39ce-4f7f-bc2b-3afcf67a38b1.pdf",
            "news_date": "2022-11-16 14:49:05",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q2FY23",
            "news_id": "2fd59244-b1a2-438a-8ba3-0e5b0e99298f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a06302aa-c8c6-405c-becd-4a7cd4ee6f1f.pdf",
            "news_date": "2022-11-15 13:25:03",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Press Release",
            "news_body": "Press Release: IOL Chemicals and Pharmaceuticals Reports Q2 FY23 Results",
            "news_id": "0e144dc3-c1c8-4ce9-bf10-044bbf5ecfe1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02e8b81e-d0bc-4ba5-a44f-4e19b8bcc111.pdf",
            "news_date": "2022-11-14 18:59:46",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Dated 14Th November 2022 And Submission Of Audited Financial Results For The Quarter And Half Year Ended 30Th September 2022",
            "news_body": "Pursuant to Regulations 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 14th November 2022 has inter alia considered and approved:<BR> <BR> 1. The Audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September 2022. Copy of the said Financial Results along with unmodified Auditors Report thereon is enclosed herewith as Annexure 1.<BR> <BR> 2. Conversion of Unit 9 as multiproduct facility to manufacture other pharma products.<BR> <BR> We hereby confirm and declare that Auditors Report issued by the Statutory Auditors on the financial results of the Company for the quarter and half year ended 30th September 2022 is an Unmodified Report. The meeting of Board of Directors commenced at 4:30 PM and concluded at 6:15 PM.<BR> <BR> The above Audited Financial Results are also available on the website of the Company i.e. www.iolcp.com.",
            "news_id": "c49c6c86-7470-4fab-9eb5-f9c22876d1c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25344dfb-468c-47d5-9de7-f8ab999ba1b8.pdf",
            "news_date": "2022-11-14 18:27:49",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1 FY 2023 Earnings Conference Call dated 10th August 2022",
            "news_id": "3c32840b-5ea4-4dd3-92d7-40ea9babde8f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e45397f-bca8-494a-b0d7-2bd5b8fdba56.pdf",
            "news_date": "2022-08-16 15:05:06",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Analysts/Investors Conference Call Pertaining To The Financial Results For Q1 & FY23",
            "news_body": "Audio Recording of Analysts/Investors Conference Call pertaining to the Financial Results for Q1 & FY23",
            "news_id": "402e0e1a-66c9-47d4-87ae-51ed11330012",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85cbb6ea-d366-4a66-ad53-9ce30f5c3308.pdf",
            "news_date": "2022-08-10 18:32:04",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q1FY23",
            "news_id": "4cd360c1-118a-4a29-9d9e-6f085805d1fb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae609198-496b-463c-b0d3-53d43dff44c2.pdf",
            "news_date": "2022-08-10 15:05:47",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 9Th August 2022 And Submission Of Audited Financial Results For The Quarter Ended 30Th June 2022",
            "news_body": "Outcome of the Board Meeting dated 9th August 2022 and submission of Audited Financial Results for the quarter ended 30th June 2022",
            "news_id": "9f086ab9-3ab4-4e13-8294-fd1689a5e842",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd31aa00-844c-4fef-922d-354685bc107b.pdf",
            "news_date": "2022-08-09 20:10:13",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter Ended 30Th June 2022",
            "news_body": "Outcome of the Board Meeting dated 9th August 2022 and submission of Audited Financial Results for the quarter ended 30th June 2022",
            "news_id": "d2df9cb1-0013-4a63-b9e0-25d9e00b1a65",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7933a53b-7d26-4ddc-8ba0-6b858208c250.pdf",
            "news_date": "2022-08-09 20:06:36",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transaction",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions in the format specified under SEBI Circular No. SEBI/HO/CFD/CMDl/OR/P/2021/662 dated 22nd November, 2021, for the half year ended on 31st March, 2022.This is for your information & record.",
            "news_id": "d24cffa2-abdb-4ae4-a9b2-03d5ce679384",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=180708f1-9d52-4c34-a94d-82d823ce5203.pdf",
            "news_date": "2022-06-14 13:37:36",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Analysts/Investors Conference Call Pertaining To The Financial Results For 4Q & FY22",
            "news_body": "Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herewith the link to the audio recording of the Analysts/Investors Call on the financial performance of the Company for the Q4 & FY22 held on Wednesday 01st June 2022.LINK: https://www.iolcp.com/uploads/Audio%20Recording%20Earnings%20Call%20Q4%20FY%202022.mp3You are requested to take the same on record.",
            "news_id": "e1930d35-45dd-4def-a9f3-fc724a73a09f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a728a0fc-fdcf-4965-9d2c-677c1bdf0718.pdf",
            "news_date": "2022-06-01 17:21:34",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q4FY22",
            "news_id": "884059d5-ce0d-40c5-8b88-55c135cc20f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=159a72f0-9b3c-4e16-8182-a312ec964f26.pdf",
            "news_date": "2022-05-31 19:21:37",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March 2022",
            "news_body": "Submission of Audited Financial Results for the quarter and year ended 31st March 2022",
            "news_id": "6914b2c2-31fa-4403-9236-62c6f58cdb50",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed44322b-e008-4abe-888b-e8696b0dbd7a.pdf",
            "news_date": "2022-05-30 20:58:59",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q3FY22",
            "news_id": "75c61898-9daf-4551-9173-792a5a3d97ac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7253f909-a664-4ead-ac0b-982e41378d83.pdf",
            "news_date": "2022-02-07 17:52:34",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Nine Months Ended 31St December 2021.",
            "news_body": "Outcome of the Board Meeting dated 4th February 2022 and submission of Audited Financial Results for the quarter and nine months ended 31st December 2021.",
            "news_id": "72886d87-496a-4595-a898-57af9d56fee5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d08da4d-7000-4fbf-8960-eb8edbad03b6.pdf",
            "news_date": "2022-02-04 18:30:06",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q2 FY22",
            "news_id": "40701bca-394a-47b0-819a-28d65122b8c7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=accc1c20-f55e-4460-8974-846ff2be0fe5.pdf",
            "news_date": "2021-11-15 18:03:18",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Half Year Ended 30Th September 2021",
            "news_body": "Pursuant to Regulations 30 & 33 read with para A. 4. h of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations (Listing Regulations), we wish to inform you that the Board of Directors in its meeting held on today i.e. 12th November 2021 has inter alia considered and approved the Audited Financial Results for the Quarter and half year ended 30th September 2021. Copy of the said financial results along with unmodified Auditors Report thereon is enclosed herewith.<BR> <BR> We hereby confirm and declare that Auditors Report issued by the Statutory Auditors on the financial results of the Company for the quarter and half year ended 30th September 2021 is an Unmodified Report. The meeting of Board of Directors commenced at 03:30 PM and concluded at 5:25 PM.<BR> <BR> The above Audited Financial Results are also available on the website of the Company i.e. www.iolcp.com.<BR> <BR> This is for your information & record.",
            "news_id": "743254d8-740f-4037-8717-5a8e2caef73d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7b8972d-94d2-46fe-a795-8e0e426a5e4d.pdf",
            "news_date": "2021-11-12 17:44:29",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the transcript of Earnings Conference Call organized by the Company on 20th August 2021 post declaration of audited financial results for the quarter ended 30th June 2021",
            "news_id": "c811ea4b-8c01-4bad-a849-417204459b4f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7e4ffdf-1ca8-401c-b3cb-bd9ebffa820e.pdf",
            "news_date": "2021-08-31 12:48:34",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation Q1 FY22",
            "news_id": "93926c97-c256-43ee-954a-2e6b85ad2049",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b69c17c-9cb0-4682-9ee2-16ab76df9a02.pdf",
            "news_date": "2021-08-19 19:00:10",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 13Th August 2021",
            "news_body": "Outcome of the Board Meeting dated 13th August 2021 and submission of Audited Financial Results for the quarter ended 30th June 2021.",
            "news_id": "77c426cf-9632-4609-aa85-8c70edc8364d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6f83dbb-922e-49b0-b3ee-7bdbc34d0cab.pdf",
            "news_date": "2021-08-13 18:55:02",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter Ended 30Th June 2021.",
            "news_body": "Outcome of the Board Meeting dated 13th August 2021 and submission of Audited Financial Results for the quarter ended 30th June 2021.",
            "news_id": "ce4f2aba-3bd3-4fa4-8a53-27a7e5c48183",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9bc076b-cb5d-4dcc-8b8f-e1265e4922ae.pdf",
            "news_date": "2021-08-13 18:50:12",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Dear Sir,<BR> <BR> In continuation to our letter dated 14th June 2021 regarding intimation of Schedule of analyst/ investors conference call - Q4 & FY2021, please find attached herewith the transcript of Earnings Conference Call organized by the Company on 15th June 2021 post declaration of audited financial results for the quarter and year ended 31st March 2021.<BR> <BR> This is for your information and records.<BR>",
            "news_id": "802f5ea9-7c42-4b5c-96ce-53366600f4bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9190227-e1e8-4e63-8516-8b1f9911be6b.pdf",
            "news_date": "2021-06-19 13:33:35",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "04745400-19f8-4597-a843-2b5b62d17883",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed91bcfd-ab56-4357-a9b7-e20696df5068.pdf",
            "news_date": "2021-06-14 18:18:03",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed herewith Disclosure of related party transactions for the year ended 31st March 2021.<BR> <BR>",
            "news_id": "6da23c08-d736-448f-9a20-3f9cbed35634",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66b9356d-15c5-4d51-bdd7-51e6084463c2.pdf",
            "news_date": "2021-06-04 19:43:01",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Dt 4Th June 2021 And Submission Of Audited Financial Results For The Quarter And Year Ended 31St March 2021",
            "news_body": "Outcome of the Board Meeting dated 4th June 2021 and submission of Audited Financial Results for the quarter and year ended 31st March 2021",
            "news_id": "72ad6ef2-8319-4b78-846e-4b3d0b96b47d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45698415-75d3-4aa2-9e72-7bf1abaf020b.pdf",
            "news_date": "2021-06-04 19:37:22",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March 2021",
            "news_body": "Outcome of the Board Meeting dated 4th June 2021 and submission of Audited Financial Results for the quarter and year ended 31st March 2021",
            "news_id": "f25ecf3c-a3f8-4b1a-9bce-227a21c37f2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2490f8c-003e-4a1b-a606-c34e26c259ab.pdf",
            "news_date": "2021-06-04 19:34:45",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation to our letter dated 15th February 2021 regarding intimation of Schedule of analyst/ investors conference call - Q3 & 9MFY21, please find attached herewith the transcript of Earnings Conference Call organized by the Company on 17th February 2021 post declaration of audited financial results for the quarter and nine months period ended 31st December 2020.",
            "news_id": "eef020a4-cf8c-4ad2-b52b-aa493668cb67",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54b079b8-a3f0-41db-b246-3fc43cf3570b.pdf",
            "news_date": "2021-03-01 17:50:05",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "IOLCP",
            "disp": "IOL Chemicals & Pharmaceuticals",
            "bse_code": 524164,
            "isin": "INE485C01029",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "4ea6c39d-8daa-4c51-950d-f54b679d20f5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7a3ccef-caaa-428e-9d30-00613105deed.pdf",
            "news_date": "2021-02-16 17:50:32",
            "seo": "iol-chemicals-and-pharmaceuticals-ltd",
            "ltp": 75.3,
            "ch": -5.650000000000006,
            "pch": -6.97961704756023,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 20413,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}